These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23298160)

  • 1. A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.
    Apolloni A; Lin MH; Sivakumaran H; Li D; Kershaw MH; Harrich D
    Hum Gene Ther; 2013 Mar; 24(3):270-82. PubMed ID: 23298160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.
    Rustanti L; Jin H; Li D; Lor M; Sivakumaran H; Harrich D
    Virol Sin; 2018 Apr; 33(2):142-152. PubMed ID: 29541943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes.
    Rustanti L; Jin H; Lor M; Lin MH; Rawle DJ; Harrich D
    Virol J; 2017 Mar; 14(1):52. PubMed ID: 28288662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong
    Jin H; Sun Y; Li D; Lin MH; Lor M; Rustanti L; Harrich D
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.
    Lin MH; Apolloni A; Cutillas V; Sivakumaran H; Martin S; Li D; Wei T; Wang R; Jin H; Spann K; Harrich D
    J Virol; 2015 May; 89(9):4827-36. PubMed ID: 25673710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
    Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
    Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of HIV-1 replication by a Tat mutant.
    Meredith LW; Sivakumaran H; Major L; Suhrbier A; Harrich D
    PLoS One; 2009 Nov; 4(11):e7769. PubMed ID: 19901984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
    Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
    Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells.
    Okamoto M; Chono H; Kawano Y; Saito N; Tsuda H; Inoue K; Kato I; Mineno J; Baba M
    Hum Gene Ther Methods; 2013 Apr; 24(2):94-103. PubMed ID: 23442049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.
    Farazmandfar T; Haghshenas MR; Shahbazi M
    Hum Gene Ther; 2015 Oct; 26(10):680-7. PubMed ID: 26077977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
    Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible expression of the deltaNGFr/F12Nef fusion protein as a new tool for anti-human immunodeficiency virus type 1 gene therapy.
    Muratori C; Schiavoni I; Melucci-Vigo G; Olivetta E; Santarcangelo AC; Pugliese K; Verani P; Federico M
    Hum Gene Ther; 2002 Sep; 13(14):1751-66. PubMed ID: 12396627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific transduction of HIV-1 envelope expressing cells by retroviral vectors pseudotyped with hybrid CD4/CXCR4 receptors.
    Bittner A; Mitnacht-Kraus R; Schnierle BS
    J Virol Methods; 2002 Jun; 104(1):83-92. PubMed ID: 12020795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
    Yu J; Liang C; Liu SL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction.
    Fortin JF; Barat C; Beauséjour Y; Barbeau B; Tremblay MJ
    J Biol Chem; 2004 Sep; 279(38):39520-31. PubMed ID: 15258149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes.
    Bahner I; Zhou C; Yu XJ; Hao QL; Guatelli JC; Kohn DB
    J Virol; 1993 Jun; 67(6):3199-207. PubMed ID: 8388497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.